BETHANY PENNINGTON: Open Payments
NPI 1598310450 · INEZ, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 36 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $235 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $318 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $162 |
| Amgen Inc. | 4 | $60 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $6 |
Products named: QULIPTA, CAPLYTA, UBRELVY, TRELEGY ELLIPTA, REPATHA, OTEZLA, AIRSUPRA, JOURNAVX.
Industry payments across KY — which companies pay providers there.
